Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Delignat

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Immunology Letters|January 24, 2006
Pathophysiology of catalytic antibodiesSébastien Lacroix-Desmazes, Bharath Wootla, Sandrine Delignat, et al.
Biochemistry|May 8, 2012
Thermodynamic analysis of the interaction of factor VIII with von Willebrand factorJordan D Dimitrov, Olivier D Christophe, Jonghoon Kang, et al.
Molecular Immunology|March 12, 2018
Absence of a neutralizing antibody response to humanized cobra venom factor in miceMathieu Ing, Brian E Hew, David C Fritzinger, et al.
Haematologica|December 15, 2018
Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia ASandrine Delignat, Jules Russick, Bagirath Gangadharan, et al.
Cancer Letters|January 18, 2006
Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanomaJean-Paul Duong Van Huyen, Sandrine Delignat, Jagadeesh Bayry, et al.
European Journal of Immunology|July 2, 2026
Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading EnzymeEmna Hannachi, Robin V Lacombe, Amélia Trecco, et al.
Immunology Letters|May 1, 2007
Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factorsSuryasarathi Dasgupta, Ana-Maria Navarrete, Sandrine Delignat, et al.
European Journal of Immunology|December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion TechnologyVictoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
Arzneimittel-Forschung|August 25, 2006
Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts IscadorSriramulu Elluru, Jean-Paul Duong Van Huyen, Sandrine Delignat, et al.
BMC Cancer|June 6, 2008
Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancerSri Ramulu Elluru, Jean-Paul Duong van Huyen, Sandrine Delignat, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Immunology Letters|January 24, 2006
Pathophysiology of catalytic antibodiesSébastien Lacroix-Desmazes, Bharath Wootla, Sandrine Delignat, et al.
Biochemistry|May 8, 2012
Thermodynamic analysis of the interaction of factor VIII with von Willebrand factorJordan D Dimitrov, Olivier D Christophe, Jonghoon Kang, et al.
Molecular Immunology|March 12, 2018
Absence of a neutralizing antibody response to humanized cobra venom factor in miceMathieu Ing, Brian E Hew, David C Fritzinger, et al.
Haematologica|December 15, 2018
Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia ASandrine Delignat, Jules Russick, Bagirath Gangadharan, et al.
Cancer Letters|January 18, 2006
Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanomaJean-Paul Duong Van Huyen, Sandrine Delignat, Jagadeesh Bayry, et al.
European Journal of Immunology|July 2, 2026
Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading EnzymeEmna Hannachi, Robin V Lacombe, Amélia Trecco, et al.
Immunology Letters|May 1, 2007
Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factorsSuryasarathi Dasgupta, Ana-Maria Navarrete, Sandrine Delignat, et al.
European Journal of Immunology|December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion TechnologyVictoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
Arzneimittel-Forschung|August 25, 2006
Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts IscadorSriramulu Elluru, Jean-Paul Duong Van Huyen, Sandrine Delignat, et al.
BMC Cancer|June 6, 2008
Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancerSri Ramulu Elluru, Jean-Paul Duong van Huyen, Sandrine Delignat, et al.
Pageof 7